2018 American Transplant Congress
Psychotic Disorders and Outcomes after Kidney Transplantation
Background: The prevalence of bipolar disorder and schizophrenia combined is around 1-4% in the general population and both represent relative contraindications for kidney transplantation. However,…2018 American Transplant Congress
Patient and Transplant Outcome in Infants Starting Renal Replacement Therapy before Two Years of Age
Introduction: Despite major technical improvement in the care of children requiring renal replacement therapy (RRT) before two years of age, the management of those patients…2018 American Transplant Congress
Age Difference between Donor and Recipient Predisposes to Early Interstitial Fibrosis and Tubular Atrophy in Pediatric Kidney Transplantation
Pediatric Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Introduction: Previous studies in adult kidney transplant recipients (KTRs) have shown that an increased age difference between donor and recipient increases the risk of arterial…2018 American Transplant Congress
Is BMI > 35 a Barrier to Kidney Transplantation?
Organ Transplant, University of Illinois, Chicago, IL.
Background:Although lower rates of patient and graft survival are reported for kidney transplant recipients with BMI > 35, kidney transplant in this group provides a…2018 American Transplant Congress
Lower Incidence of De Novo Donor-Specific Antibodies against HLA-DR in ABO-Incompatible Renal Transplantation
IntroductionDe novo DSA-induced chronic antibody-mediated rejection (AMR) is one of major obstacles to long term graft survival. We have reported that anti-A/B antibody binding could…2018 American Transplant Congress
Liver Transplant Recipients with End-Stage Renal Disease Largely Benefit from Kidney Transplantation
Background: The incidence of end-stage renal disease (ESRD) following liver transplant (LT) has increased. The actual benefit of kidney transplantation (KT) is not completely understood…2018 American Transplant Congress
Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients
Background. Many immunosuppressive drugs are prescribed as twice-daily dosing. Simplified once-daily dosing of the entire drug regimen can improve treatment satisfaction for patients. We examined…2018 American Transplant Congress
Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection
BackgroundInfectious complications under immunosuppressive therapy are inevitable problems. Viral infection (include reactivation) occurs at a certain frequency even if immunosuppressive agents are totally adjusted by…2018 American Transplant Congress
β-Glucuronidase Gene Expression in Stool Samples Associated with Chronic Allograft Dysfunction in Kidney Transplants
Background: Myocophenolate mofetil (MMF) is a prodrug that is extensively and rapidly converted to the active component, mycophenolic acid (MPA). MPA undergoes extensive enterohepatic recycling…2018 American Transplant Congress
Attitudes of African Canadian Patients with End Stage Kidney Disease toward Living Donor Kidney Transplantation
University Health Network, Toronto, ON, Canada.
Background:African Canadian patients with end stage kidney disease (ESKD) are less likely to receive a living donor kidney transplant (LDKT) compared to Caucasian Canadians. We…
- « Previous Page
- 1
- …
- 277
- 278
- 279
- 280
- 281
- …
- 531
- Next Page »